Immune Pharmaceuticals (IMNPQ)
OTHER OTC:IMNPQ
Holding IMNPQ?
Track your performance easily

Immune Pharmaceuticals (IMNPQ) Financial Statements

0 Followers

Immune Pharmaceuticals Financial Overview

Immune Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Immune Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 18Jun 18Mar 18Dec 17Sep 17
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -3.63M$ -4.44M$ -4.32M$ -6.10M$ -4.61M
EBITDA$ -3.42M$ -4.21M$ -4.09M$ -5.87M$ -4.36M
Net Income Common Stockholders$ -9.67M$ -10.32M$ -4.38M$ -10.01M$ -6.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 76.00K$ 1.51M$ 2.73M$ 6.78M-
Total Assets$ 20.72M$ 22.26M$ 24.33M$ 28.61M$ 22.31M
Total Debt$ 4.04M$ 4.73M$ 6.98M$ 8.60M$ 7.46M
Net Debt$ 3.97M$ 3.22M$ 4.24M$ 1.83M$ 7.46M
Total Liabilities$ 19.87M$ 17.61M$ 14.97M$ 14.85M$ 21.74M
Stockholders Equity$ 573.00K$ 842.00K$ 4.66M$ 9.36M$ 13.76M
Cash Flow-
Free Cash Flow$ -1.53M$ -3.19M$ -3.72M$ -6.35M$ -764.00K
Operating Cash Flow$ -1.50M$ -3.16M$ -3.69M$ -6.34M$ -764.00K
Investing Cash Flow$ -38.00K$ -30.00K$ -31.00K$ -6.00K$ 0.00
Financing Cash Flow$ 101.00K$ 1.96M$ -319.00K$ 13.05M$ 818.00K
Currency in USD

Immune Pharmaceuticals Earnings and Revenue History

Immune Pharmaceuticals Debt to Assets

Immune Pharmaceuticals Cash Flow

Immune Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis